| Medical Mutual | Biomarker Testing for Multiple Sclerosis and Related Neurologic Diseases | 2025-09-04 |
| Medical Mutual | Arranon® (nelarabine) (Intravenous) | 2025-09-04 |
| Medical Mutual | Bendamustine: Belrapzo® (Intravenous) | 2025-09-04 |
| Medical Mutual | Oncology Value: Cyramza® (ramucirumab) (Intravenous) (EOV) | 2025-09-04 |
| Medical Mutual | Elahere® (mirvetuximab soravtansine-gynx) (Intravenous) | 2025-09-04 |
| Medical Mutual | Oxaliplatin (Intravenous) | 2025-09-04 |
| Medical Mutual | Halaven® (eribulin) (Intravenous) | 2025-09-04 |
| Medical Mutual | Ixempra® (ixabepilone) (Intravenous) | 2025-09-04 |
| Medical Mutual | Susvimo® (ranibizumab) (Intravitreal) | 2025-09-04 |
| Medical Mutual | Syfovre® (pegcetacoplan) (Intravitreal) | 2025-09-04 |